High Vaccine Confidence Among Patients in Malaysia
Over the past year, biopharmaceutical companies have worked at an unprecedented speed to research and develop COVID-19 vaccines, treatments and diagnostics – supported by the innovation ecosystem along the way. As regulatory authorities continue to monitor the safety and efficacy of these innovations and authorize them for public use, it is important for patients to also feel confident in and accept inoculation once vaccine supply is available.
EU Commission Cites Systemic IP Barriers in Southeast Asia
Strong intellectual property (IP) protection and enforcement is critical to helping countries attract foreign investment, promote economic growth, provide greater access to medicines and improve patient outcomes. The biennial “Report on the Protection and Enforcement of Intellectual Property Rights in Third Countries” cites Malaysia, Indonesia and Thailand as priority countries that will need to strengthen their IP regulations to stay globally competitive.
IP Protections Help Improve Cancer Screening and Prevention in Malaysia
Cervical cancer is the third most common cancer in women in Malaysia, but the country’s screening rate is disproportionately low. Intellectual property protections are helping to pave the way for a new program to improve screening rates and prevention in Malaysia.
Explore the Countries
Indonesia has achieved significant health milestones, but rising rates of NCDs bring new challenges.
Malaysia can attract new foreign investment and improve health outcomes by better protecting innovation and reducing bureaucratic delays.
Increasing public-private partnerships in the Philippines will bring health care innovation to a rapidly growing population
Health care is poised to become a major economic driver in Thailand in the coming years.
The success of Singapore’s health care system can be attributed to strong policies and an integrated health system.